M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium

The Journal of Urology - Tập 139 Số 3 - Trang 461-469 - 1988
Cora N. Sternberg1,2, Alan Yagoda1,2, Howard I. Scher1,2, Robin C. Watson1,2, Harry W. Herr1,2, Michael J. Morse1,2, Pramod C. Sogani1,2, E. Darracott Vaughan1,2, Neil H. Bander1,2, Lora Weiselberg1,2, Nancy L. Geller1,2, Phyllis Hollander1,2, Roberta Lipperman1,2, William R. Fair1,2, Willet F. Whitmore1,2
1Division of Urology, Department of Surgery, New York Hospital and Don Monti Division of Oncology, Department of Medicine, North Shore University Hospital, Manhasset, New York
2From the Solid Tumor Service, Department of Medicine, Department of Diagnostic Radiology, Division of Biostatistics, Department of Epidemiology and Biostatistics, and Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, and Cornell University Medical College, New York

Tóm tắt

Từ khóa


Tài liệu tham khảo

Sternberg, 1985, Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium, J. Urol., 133, 403, 10.1016/S0022-5347(17)48996-8

1987, Ad Hoc Working Group for Critical Appraisal of the Medical Literature: A proposal for more informative abstracts of clinical articles, Ann. Intern. Med., 106, 598, 10.7326/0003-4819-106-4-598

Yagoda, 1985, Progress in the treatment of advanced urothelial tract tumors, J. Clin. Oncol., 3, 1448, 10.1200/JCO.1985.3.11.1448

VanOosterom, 1986, Response criteria phase II/phase III invasive bladder cancer, 301

Sternberg, 1987, Advances in the treatment of urothelial tract tumors, Urol. Clin. N. Amer., 14, 373, 10.1016/S0094-0143(21)00576-0

Yagoda, 1987, Chemotherapy of urothelial tract tumors, Cancer, 60, 574, 10.1002/1097-0142(19870801)60:3+<574::AID-CNCR2820601524>3.0.CO;2-C

Kaplan, 1958, Nonparametric estimation from incomplete observations, J. Amer. Stat. Ass., 53, 457, 10.1080/01621459.1958.10501452

Miller, 1981, 44

Feinstein, 1985, The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer, New Engl. J. Med., 312, 1604, 10.1056/NEJM198506203122504

Smith, 1981, Regional lymph node metastasis from bladder cancer, J. Urol., 126, 591, 10.1016/S0022-5347(17)54638-8

Scher, 1988, Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion, J. Urol., 139, 470, 10.1016/S0022-5347(17)42495-5

Scher, 1988, Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors, J. Urol., 139, 475, 10.1016/S0022-5347(17)42496-7

Hasun, 1987, M-VAC for recurrent urothelial tumor after radical surgery, 149

Chong, 1987, M-VAC as salvage chemotherapy in transitional cell carcinoma (TCC) of the urothelium previously treated with cisplatin combination chemotherapy, Proc. Amer. Ass. Cancer Res., 28, 204

Harker, 1985, Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group study, J. Clin. Oncol., 3, 1463, 10.1200/JCO.1985.3.11.1463

Meyers, 1985, The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study, J. Urol., 134, 1118, 10.1016/S0022-5347(17)47651-8

Meyers, 1987, The sequential analysis of DNA content in transitional cell carcinoma (TCC) of the bladder in patients undergoing combined modality therapy, Proc. Amer. Ass. Cancer Res., 28, 79

Thông tin
Thông tin xuất bản

The Journal of Urology

Tập 139 Số 3

461-469

Thông tin tác giả